PAR vs SPL

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

PAR

PARA BIO FPO [PAR]

49LOW

SPL

STARPHARMA FPO [SPL]

49LOW

Score Breakdown

PAR SPL
Technical
68
48
Catalyst
67
65
Sentiment
50
50
Fundamental
48
72
Momentum
52
82
Risk Gate
50
50

Key Metrics

PAR Metric SPL
$113.5MMarket Cap$195.3M
910KAvg Volume (20d)1.7M
+0.4%Short Interest+0.1%
$0.48052-Week High$0.525
$0.24052-Week Low$0.082
+2.8%Daily Change+0.0%
$0.257Entry Price$0.465
-180.2%ROE-14.5%
N/AProfit Margin-22.2%

Active Signals

PAR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (13426.2x)
●Strong revenue growth (+51%)

SPL Signals

●Stochastic is stretched into overbought — could need a breather
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)
●Moderate P/S ratio (13.4x)
●Strong revenue growth (+360%)
●EPS estimates revised downward (-10pts)

Ask Scout AI to compare PAR and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
PAR Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).